View Online
December 5th, 2019
It's so easy to renew your ABC membership for 2020!
If you haven't yet renewed, click here now.

News From Medscape
The following recommended articles on are freely available through the partnership between ABC and Medscape, no registration or login required.
AMA Backs More Healthcare Economics Education for Med Students
The American Medical Association (AMA) is expanding its effort to put more emphasis on healthcare economics in the education of students and residents as a path to containing costs. The group recently called on medical schools and residency programs to include materials on cost-effective use of diagnostic services and treatments, risk management, practice management, and quality assurance.
Male Clinicians Miss Microaggressions Their Female Peers Notice
Men underestimate how often women experience microaggressions in clinic and hospital settings, according to a study published online in Academic Medicine. Study participants viewed videos depicting situations in which microaggressions — "subtle verbal or nonverbal everyday behaviors that arise from unconscious bias, covert prejudice, or hostility" — did and did not occur.
Treating LDL to Below 70 Reduces Recurrent Stroke
Treating patients to a lower LDL target after an ischemic stroke of atherosclerotic origin resulted in fewer recurrent strokes or major cardiovascular events compared with a higher LDL goal, even though the international trial was stopped early because of a lack of funding.
Nature vs Nurture: What's Fueling the Obesity Epidemic?
The obesity epidemic is not simply the result of changes in the lived environment but a complex interplay between genes and surroundings that has driven people who would have been genetically susceptible — but remained thin in previous eras — to become obese, says one expert.
Items of Interest
AstraZeneca Launches "Diabetes Can Break Your Heart" Campaign for World Diabetes Day
In honor of World Diabetes Day, AstraZeneca announced the launch of Diabetes Can Break Your Heart, a national movement with a goal to change the trajectory of heart failure (HF) in type 2 diabetes (T2D). The initiative is designed to raise awareness, create community action and spark dialogue between those with T2D and their healthcare providers to help reduce the risk of HF—one of the earliest and most frequent cardiac complications for people living with T2D, often before heart attack or stroke, and an urgent public health issue. Organizations such as the American Association of Clinical Endocrinologists (AACE), American Association of Diabetes Educators (AADE), and the Association of Black Cardiologists, Inc. (ABC) have joined the campaign to spread the message to more communities nationwide.
Expanding Access to Potentially Lifesaving Cardiovascular Treatments
By Keith C. Ferdinand and Elena V. Rios
ABC Access to Care Initiative Chair Dr. Keith C. Ferdinand and National Hispanic Medical Association’s President / CEO Dr. Elena V. Rios published an Op-Ed in The Washington Times on how payers can help increase access to PCSK9 inhibitors for minority and low-income heart patients by covering at least one PCSK9 inhibitor on a preferred, lower cost sharing tier and ensure all patients get the CVD treatments they need at a more affordable rate.
Heart Disease and Cancer Risk May Be Linked
Heart attack survivors may have an increased risk of developing cancer compared to people without cardiovascular disease, according to research at the American Heart Association's Scientific Sessions 2019 in Philadelphia. People with more risk factors for cardiovascular diseases were also at higher risk for developing cancer compared to people with lower cardiovascular disease risk.
Number of Cardiovascular Deaths Rising Among Cancer Survivors, Study Finds
More people than ever have survived cancer in the United States. That’s the good news. But the bad news for the 17 million survivors—two-thirds of whom have lived 5 years more—is that more than 1 in 10 will die from cardiovascular disease (CVD), according to a new study published in the European Heart Journal.
Novartis Buys The Medicines Company: A $9.7 Billion Gamble on a PCSK9 Cholesterol Drug
A week after The Medicines Company announced positive data from ORION-10, (ORION-10: siRNA Tx Halves LDL in Atherosclerotic CVD) the second of three 19-month Phase III trials for inclisiran for lowering cholesterol, Novartis announced it was acquiring the company for $9.7 billion. The boards of both companies have unanimously approved the acquisition.
Smartphone App Reminds Heart Patients To Take Their Pills
Heart patients using a smartphone app reminder are more likely to take their medication than those who receive written instructions, according to a study presented at the 45th Argentine Congress of Cardiology (SAC 2019).
Dapagliflozin Has Benefits Across Heart Failure Subgroups
Dapagliflozin (Farxiga; AstraZeneca), originally developed for the treatment of type 2 diabetes, has a broad, positive impact across various subsets of patients with chronic heart failure and reduced ejection fraction (HFrEF), including those without diabetes, according to new data out of the DAPA-HF trial. The SGLT2 inhibitor had a consistent impact regardless of diabetes status, age, and health status.
Featured Articles by Members
ABC Members: We welcome your published research submissions and articles for inclusion in future issues of Clinical Updates and Insights. Email Rachel Williams at and please attach file or include links to the original published work and/or abstract.
Abstract 12574: Mindfulness and Lifestyle Medicine Lowers Blood Pressure in Hypertension
Co-authored by Karol E. Watson (with Eunjoo An, Mary-Lynn Brecht, Lynn V. Doering, Michael R. Irwin, and Paul M. Macey)
Hypertension (HTN) is the leading modifiable cardiovascular risk factor affecting 103 million adults in the US. A healthy diet and regular physical activity are key components in lifestyle medicine for maintaining normal blood pressure (BP). Yet, most Americans struggle making these changes. We evaluated the effects of mindfulness practice on lifestyle behaviors and BP. The objective of the study was to determine if mindfulness practice would improve lifestyle behaviors and BP in patients with HTN, relative to health education only.
Abstract 15246: Nutrition Intervention, Lipids and Biomarkers of Risk in African Americans: Help Everyone Assess Risk Today: Lenten Nutrition Study: "Giving up Unhealthy Food for Lent"
Co-authored by Setri Fugar and Kim Allan A. Williams (with Ibtihaj A. Fughhi, Michael Dansinger, Sharon Gates, Ronald McDaniel, Jochen Reiser, Hena Patel, Darrius Chambers and Terry Mason)
Previous studies indicate that nutritional factors contribute to the higher cardiovascular disease (CVD) event risk in African Americans (AAs), and that change to healthier diet may decrease these underpinning risk factors. This study evaluated the impact of a nutrition intervention in AA’s on risk factors and biomarkers associated with CVD, hypothesizing that a change to a completely plant-based diet would improve such factors.
Abstract 16164: Effect of Change in Cumulative Psychosocial Stressors on Change in Body Mass Index Over Time
Co-authored by Jonathan Z. Butler, Tiffany M. Powell-Wiley and Michelle A. Albert (with Eva M. Durazo, Rimma Dushkes, Natalie Bea Slopen, David R. Williams, and Julie E. Buring)
Increased psychosocial stress and obesity are both associated with elevated risk of cardiovascular disease (CVD). However, the effect of change in cumulative psychosocial stressors on change in body mass index (BMI) over time is unknown, particularly among older women, a population in whom weight change characterization is complex.

We LOVE to LEARN how our ABC Members are making a difference! Please Share. Giving a keynote speech? Presenting at a Grand Round? Receiving an Award? Interviewed by the Press? Published in a journal? Presenter or Panelist at a Conference? Graduating? Email Rachel Williams at or please tag or DM us on Facebook, Twitter or Instagram with links/details, so we can spotlight your excellence in our newsletter!

Upcoming Events

Policy Pulse Live:
Access to Amyloidosis Treatments

Wednesday, December 11, 2019

6:30p – 7:00p | Registration
7:00p – 8:30p | Program

One Ocean Resort & Spa | Pristina Room
One Ocean Boulevard | Atlantic Beach, FL 32233

Keynote Speaker: Taimur Sher, MBBS, MD
Associate Professor of Medicine
Department of Hematology and Oncology
Mayo Clinic
Local Host: Gladys P. Velarde, MD, FACC, FAHA
Associate Professor of Medicine
Director Women’s Cardiovascular Health Program
Director Cardiovascular Fellowship Program
University of Florida College of Medicine-Jacksonville
Division of Cardiology

RSVP by Monday, December 2nd | Seating is limited


This email was sent to ##email## by Association of Black Cardiologists, powered by Powered by Multiview's Content Marketing
Archive | View Online | Unsubscribe | Subscribe